Pfizer pays $5.2bn in cash for Anacor
Pfizer Inc. is paying $5.2bn--$99.25 per share, a 57% premium--in cash to acquire Anacor Pharmaceuticals Inc. The purchase price is net of cash and assumes the conversion of Anacor’s outstanding convertible debt.
- Full Acquisition
- Includes Contract
- Payment Includes Cash
Please contact Sales at: (212) 520-2765 or email [email protected]
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.